SPECIALTY TOPICS · GUIDE
Single-Cell Analysis and Spatial Biology
What single-cell sequencing and spatial transcriptomics measure, what they have added to research, and why cell maps and gene-activity patterns are not diagnoses or treatments.
Content last updated . This page has not been medically reviewed.
Back to Emerging Wellness ScienceWhat these methods do
Standard lab tests often average a whole tissue sample. Single-cell RNA sequencing measures gene expression, which is the activity of genes, cell by cell, and has allowed gene expression to be studied at an unprecedented resolution. [1] Thousands, or even millions, of cells can be analyzed in one experiment, which creates new data science problems. [2] Spatial transcriptomics adds location: it uses high-throughput technologies to quantify gene expression in space, because the function of embryos, liver lobules, intestinal villi and tumors depends on how their cells are arranged. [3] Both are research tools. This page is information only.What they contribute
- Cell types and states. A typical analysis goes through quality control, normalization, data correction, feature selection and dimensionality reduction before cells are grouped and compared. [1]
- Context. Spatial methods keep track of where in a tissue the signal came from, which matters for tumors and other tissues with structure. [3]
- Hypotheses. Cell atlases and maps of tissue help researchers decide what to study next, for example how different cell types behave in a disease.
What they cannot establish
- A diagnosis or a treatment. A pattern of gene activity in a research sample is not a validated clinical test. See clinical validity and clinical utility.
- Cause. A gene-expression difference between samples shows an association. See mechanism vs demonstrated benefit.
- Complete measurement. A review of spatial transcriptomics in thyroid cancer lists technical limitations, including low resolution and sequencing depth, the need for high-quality samples, and complex data handling. [4]
- Easy analysis. The field lists open data science challenges, and many analysis tools exist, making it hard to choose a workflow. [2][1]
- Outcomes in people. A map of cells is not a trial. I did not read a source showing that single-cell results alone improved patient outcomes. Proper evidence not found for that question in the sources checked.
Where you may meet these terms
Research news may say that single-cell work "reveals" a new cell type or "pinpoints" a cause of a disease. Ask what was measured, in which tissue and how many people, and whether anything was tested beyond a pattern. Commercial wellness tests that borrow the language of single-cell or spatial research should be read as a marketing claim unless a published validation study of that exact test exists. See multi-omics explained and biomarker discovery research.Why the technical details matter to a reader
Cells in a dish are not tissue in a body, and one tissue sample at one moment is a snapshot. The more steps in a pipeline, the more places for noise or choices to change the result, which is why reviews publish best-practice recommendations for each step. [1] Low resolution is one of the technical limits listed for spatial methods. [4]Frequently asked questions
What is single-cell sequencing in simple terms?
It measures gene activity in individual cells instead of averaging a whole sample. [1]
How is spatial biology different?
It adds where in a tissue the gene activity is happening. [3]
Can these methods diagnose disease?
Not by themselves. They are research tools, and their limits include resolution, sequencing depth and sample quality. [4]
Are single-cell results proof of a cause or cure?
No. They describe patterns that then need testing; see our page on mechanism and demonstrated benefit.
More details: evidence, limits and cautions
The details behind this page: cautions, limits of the evidence and where sources disagree. Open any note to read it.
How to read the evidence labels
Labels used on this page: preclinical (cells/animals only) is laboratory evidence; insufficient evidence means the question cannot yet be answered; marketing claim is a statement with no supporting human trial. Related definitions are in genomics explained and transcriptomics, proteomics and metabolomics.
Safety note
References
- Current best practices in single-cell RNA-seq analysis: a tutorial (Molecular Systems Biology, 2019). Read 2026-10-22.
- Eleven grand challenges in single-cell data science (Genome Biology, 2020). Read 2026-10-22.
- Museum of spatial transcriptomics (Nature Methods, 2022). Read 2026-10-22.
- Spatial Transcriptomics in Thyroid Cancer: Applications, Limitations, and Future Perspectives (Cells, 2025). Read 2026-10-22.